Lucid EV/EBITDA
What is the EV/EBITDA of Lucid?
The EV/EBITDA of Lucid, Inc. is N/A
What is the definition of EV/EBITDA?
EV/EBITDA is enterprise value divided by earnings before interest, tax, depreciation, and amortization. It is a measure of how expensive a stock is and is more frequently valid for comparisons across companies than the price to earnings ratio. It measures the price (in the form of enterprise value) an investor pays for the benefit of the company’s cash flow (in the form of EBITDA).
= enterprise value / EBITDA
Price to earnings ratios are impacted by a company's choice of capital structure - companies which raise money via debt will have lower P/Es (and therefore look cheaper) than companies that raise an equivalent amount of money by issuing shares, even though the two companies might have equivalent enterprise values. A sample case is when a company with debt were to raise money by issuing shares of stock, and then used the money to pay off the debt, this company's P/E ratio would shoot up because of the increased number of shares - although nothing about the fundamental value of the business has changed. EV / EBITDA is unaffected by capital structure as enterprise value includes the value of debt, and EBITDA is available to all investors (debt and equity) as it excludes interest payments on that debt. It is ideal for analysts and potential investors looking to compare companies within the same industry.
EV/EBITDA of companies in the Health Care sector on OTC compared to Lucid
What does Lucid do?
Caliber Imaging & Diagnostics, Inc., a medical technologies company, designs, develops, and markets imaging solutions that shows tissue at the cellular level in the United States. The company provides VivaScope 1500, a reflectance confocal imaging system that enables clinicians and researchers to capture confocal images that depict cellular structures of living tissue; and VivaScope 3000, a hand-held in vivo reflectance confocal microscope for skin imaging. It also offers VivaScan software to schedule patients for examinations, perform imaging examinations on one or more lesions during a visit, review, and report on images obtained during an examination, as well as VivaNet, a digital telepathology system. The company was formerly known as Lucid, Inc. and changed its name to Caliber Imaging & Diagnostics, Inc. in August 2012. Caliber Imaging & Diagnostics, Inc. was founded in 1991 and is headquartered in Andover, Massachusetts.
Companies with ev/ebitda similar to Lucid
- Pure Alumina has EV/EBITDA of N/A
- Bounty Mining has EV/EBITDA of N/A
- Calyx Ventures has EV/EBITDA of N/A
- Neuropathix has EV/EBITDA of N/A
- Xinhua News Media has EV/EBITDA of N/A
- Creo Medical Plc has EV/EBITDA of N/A
- Lucid has EV/EBITDA of N/A
- Precipitate Gold has EV/EBITDA of N/A
- Strong Petrochemical has EV/EBITDA of N/A
- ParcelPal Technology has EV/EBITDA of N/A
- Tasman Resources Ltd has EV/EBITDA of N/A
- Bankers Cobalt has EV/EBITDA of N/A
- Reitmans (Canada) has EV/EBITDA of N/A